Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results) |
The participant's perception of the treatment result being satisfactory |
24th gestational week |
|
Primary |
Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results) |
The participant's perception of the treatment result being satisfactory |
36th gestational week |
|
Primary |
Acceptability measured using a 11-point numerical scale (0 = completely dissatisfied with the treatment results; 10 = completely satisfied with the treatment results) |
The participant's perception of the treatment result being satisfactory |
From 7 to 15 days after delivery |
|
Primary |
Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises) |
Assesses whether the exercise program is suitable for the target audience or needs some adaptation |
24th gestational week |
|
Primary |
Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises) |
Assesses whether the exercise program is suitable for the target audience or needs some adaptation |
36th gestational week |
|
Primary |
Suitability measured using 2 questions (one about the need of tailored exercises for the gestational needs and the other about the need of some adaptation during the execution of the exercises) |
Assesses whether the exercise program is suitable for the target audience or needs some adaptation |
From 7 to 15 days after delivery |
|
Primary |
Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment |
Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out |
24th gestational week |
|
Primary |
Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment |
Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out |
36th gestational week |
|
Primary |
Viability measured using a form developed for this study and filled by the physical therapist responsible for the treatment |
Assesses recruitment, retention, and participation rates, whether participants reached the end of the treatment program and, if not, why they dropped out |
From 7 to 15 days after delivery |
|
Primary |
Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty) |
Assesses the level of difficulty of the selected exercises |
24th gestational week |
|
Primary |
Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty) |
Assesses the level of difficulty of the selected exercises |
36th gestational week |
|
Primary |
Fidelity measured using an exercise checklist (list of all exercises that can be performed including the level of difficulty) |
Assesses the level of difficulty of the selected exercises |
From 7 to 15 days after delivery |
|
Secondary |
Occurrence of musculoskeletal complaint |
|
24th gestational week, 36th gestational week, and from seven to 15 days after delivery |
|
Secondary |
Number of days from randomization on which the musculoskeletal complaint occurred |
|
24th gestational week, 36th gestational week, and from seven to 15 days after delivery |
|
Secondary |
Delivery mode (normal or caesarean section) |
|
From 7 to 15 days after delivery |
|
Secondary |
Apgar score (0 to 10) |
Reported at 1 minute and 5 minutes after birth, and at 5-minute intervals thereafter until 20 minutes for infants with a score less than 7 |
From 7 to 15 days after delivery |
|
Secondary |
Baby's birth weight |
|
From 7 to 15 days after delivery |
|
Secondary |
Kinesiophobia measured using the Tampa Scale of Kinesiophobia in the occurrence of musculoskeletal complaint |
The total score ranges from 17 to 68 points, and the higher the score, the greater the degree of kinesiophobia. |
24th gestational week, 36th gestational week, and from 7 to 15 days after delivery |
|
Secondary |
Disability measured using the Patient Specific Functional Scale in the occurrence of musculoskeletal complaint |
11-point numerical scale (0 = unable to perform the activity; 10 = able to perform the activity at the same level as before the injury or problem) |
24th gestational week, 36th gestational week, and from 7 to 15 days after delivery |
|
Secondary |
Pain measured using the Pain Numerical Rating Scale in the occurrence of musculoskeletal complaint |
11-point numerical scale (0 = no pain; 10 = the worst possible pain) |
24th gestational week, 36th gestational week, and from 7 to 15 days after delivery |
|
Secondary |
Costs (healthcare costs, patient and family costs, and lost productivity costs) measured using a questionnaire specially developed for this study |
|
Baseline, 24th gestational week, 36th gestational week, and from 7 to 15 days after delivery |
|